Daewoong Pharma Financial Flexibility Index
Daewoong Pharma financial flexibility index. Daewoong Pharma (069620) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of ₩129.75 Billion (operating CF ₩57.53 Billion minus capex ₩72.21 Billion) represents 0% of total liabilities (₩1.26 Trillion). Explore Daewoong Pharma capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Daewoong Pharma (2007–2024)
Financial flexibility index of Daewoong Pharma from 2007 to 2024. Historical Financial Flexibility Index trend for Daewoong Pharma across 16 annual periods. Check 069620 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Daewoong Pharma Financial Flexibility Index by Year (2007–2024)
Daewoong Pharma financial flexibility index by year from 2007 to 2024. Year-by-year free cash flow to debt coverage for Daewoong Pharma. For the full cash flow conversion analysis, see 069620 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | ₩280.50 Billion | ₩51.49 Billion | ₩1.05 Trillion | ▼ -18.9% |
| 2023 | 0.33x | ₩251.24 Billion | ₩132.57 Billion | ₩762.77 Billion | ▲ +47.6% |
| 2022 | 0.22x | ₩183.44 Billion | ₩118.21 Billion | ₩822.12 Billion | ▲ +130.2% |
| 2021 | 0.10x | ₩69.08 Billion | ₩39.99 Billion | ₩712.77 Billion | ▼ -48.9% |
| 2020 | 0.19x | ₩127.47 Billion | ₩100.98 Billion | ₩671.66 Billion | ▲ +44.8% |
| 2019 | 0.13x | ₩79.91 Billion | ₩57.60 Billion | ₩609.75 Billion | ▼ -24.7% |
| 2018 | 0.17x | ₩104.49 Billion | ₩47.50 Billion | ₩600.04 Billion | ▼ -41.4% |
| 2017 | 0.30x | ₩173.06 Billion | ₩103.94 Billion | ₩581.99 Billion | ▼ -10.1% |
| 2016 | 0.33x | ₩178.63 Billion | ₩15.38 Billion | ₩540.15 Billion | ▼ -8.0% |
| 2015 | 0.36x | ₩131.02 Billion | ₩35.89 Billion | ₩364.29 Billion | ▲ +19.4% |
| 2014 | 0.30x | ₩71.95 Billion | ₩25.95 Billion | ₩238.76 Billion | ▼ -41.9% |
| 2013 | 0.52x | ₩73.20 Billion | ₩54.16 Billion | ₩141.05 Billion | ▼ -27.8% |
| 2012 | 0.72x | ₩68.79 Billion | ₩45.02 Billion | ₩95.76 Billion | ▼ -18.4% |
| 2011 | 0.88x | ₩119.74 Billion | ₩78.82 Billion | ₩136.04 Billion | ▲ +173.8% |
| 2008 | 0.32x | ₩66.67 Billion | ₩31.33 Billion | ₩207.39 Billion | ▼ -35.8% |
| 2007 | 0.50x | ₩61.70 Billion | ₩25.81 Billion | ₩123.24 Billion | — |